Efficacy and Safety of Radiofrequency Ablation Plus Stent Versus Stent-alone Treatments for Malignant Biliary Strictures

Background/Aims: Malignant biliary strictures (MBS) are very aggressive and cannot be diagnosed in the early stages due to their asymptomatic nature. Stenting the stricture area of the biliary tree is palliative treatment but has poor survival time. Radiofrequency ablation plus stent (RFA+S) have been recently used to improve the survival and stent patency time in patients with MBS. In this systematic review and meta-analysis, we tried to evaluate the efficacy and safety of radiofrequency ablation. Materials and Methods: Study search up to December 2021 was performed in different medical databases such as PubMed, Web of Science, and Cochrane library, etc. We selected eligible studies reporting survival time, stent patency time, and adverse events in patients with MBS. We compare the outcomes of RFA+S and stent-alone treatment groups. Results: A total of 15 studies (6 randomized controlled trials and 9 observational studies) with 1815 patients were included for meta-analysis of which 701 patients were in RFA+S group and 1114 patients in the stent-alone group. Pooled mean difference of survival time was 2.88 months (95% CI: 1.78-3.97) and pooled mean difference of stent patency time was 2.11 months (95% CI: 0.91-3.30) and clinical success risk ratio was 1.05 (95% CI: 1.01–1.09). Risk ratios for adverse events are given; Bleeding 0.84 (95% CI: 0.34-2.11), abdominal pain 1.06 (95% CI: 0.79-1.40), pancreatitis 0.93 (95% CI: 0.43-2.01), cholangitis 1.07 (95% CI: 0.72-1.59), and stent dysfunction 0.87 (95% CI: 0.70-1.07). Conclusions: Radiofrequency ablation is involved in increased survival and stent patency time for MBS patients. With the help of better techniques, adverse events can be limited.

[1]  Kehu Yang,et al.  Comparative efficacy and safety of local palliative therapeutics for unresectable malignant biliary obstruction: a Bayesian network meta-analysis , 2022, Expert review of gastroenterology & hepatology.

[2]  M. Bruno,et al.  Comparison of Intraductal RFA Plus Stent versus Stent-Only Treatment for Unresectable Perihilar Cholangiocarcinoma—A Systematic Review and Meta-Analysis , 2022, Cancers.

[3]  Kehu Yang,et al.  Local palliative therapies for unresectable malignant biliary obstruction: radiofrequency ablation combined with stent or biliary stent alone? An updated meta-analysis of nineteen trials , 2022, Surgical Endoscopy.

[4]  J. Cho,et al.  Efficacy and safety of temperature‐controlled intraductal radiofrequency ablation in advanced malignant hilar biliary obstruction: A pilot multicenter randomized comparative trial , 2021, Journal of hepato-biliary-pancreatic sciences.

[5]  G. Filippini,et al.  Reliability of the revised Cochrane risk-of-bias tool for randomised trials (RoB2) improved with the use of implementation instruction. , 2021, Journal of clinical epidemiology.

[6]  J. Pánek,et al.  The combination of endoluminal radiofrequency ablation and metal stent implantation for the treatment of malignant biliary stenosis - Randomized study. , 2021, European journal of radiology.

[7]  Jun Wu,et al.  Effect of endoscopic radiofrequency ablation on the survival of patients with inoperable malignant biliary strictures: A large cohort study , 2021, Journal of hepato-biliary-pancreatic sciences.

[8]  Ling-Ling Lee.  [Application of the Risk of Bias 2 Tool]. , 2021, Hu li za zhi The journal of nursing.

[9]  Cheng-Li Liu,et al.  Improving biliary stent patency for malignant obstructive jaundice using endobiliary radiofrequency ablation: experience in 150 patients , 2021, Surgical Endoscopy.

[10]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2021, BMJ.

[11]  D. Adler,et al.  Photodynamic Therapy (PDT), Radiofrequency Ablation (RFA) With Biliary Stents in Palliative Treatment of Unresectable Extrahepatic Cholangiocarcinoma , 2021, Journal of clinical gastroenterology.

[12]  Meng Chen,et al.  Stent placement combined with intraluminal radiofrequency ablation and hepatic arterial infusion chemotherapy for advanced biliary tract cancers with biliary obstruction: a multicentre, retrospective, controlled study , 2021, European Radiology.

[13]  B. Cha,et al.  Survival Benefit of Intraductal Radiofrequency Ablation for Malignant Biliary Obstruction: A Systematic Review with Meta-Analysis , 2021, Clinical endoscopy.

[14]  Jianfeng Yang,et al.  Endoscopic radiofrequency ablation plus plastic stent placement versus stent placement alone for unresectable extrahepatic biliary cancer: a multicenter randomized controlled trial. , 2020, Gastrointestinal endoscopy.

[15]  H. Lee,et al.  Efficacy and safety of palliative endobiliary radiofrequency ablation using a novel temperature-controlled catheter for malignant biliary stricture: a single-center prospective randomized phase II TRIAL , 2020, Surgical Endoscopy.

[16]  R. Pawa,et al.  Endoscopic Management of Malignant Biliary Stricture , 2020, Diagnostics.

[17]  Halime Çevik,et al.  Percutaneous Intraductal Microwave Ablation of Malignant Biliary Strictures: Initial Experience. , 2020, AJR. American journal of roentgenology.

[18]  Xiaolin Wang,et al.  Percutaneous intraductal radiofrequency ablation combined with biliary stent placement for treatment of malignant biliary obstruction , 2020, Abdominal Radiology.

[19]  V. Welch,et al.  Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. , 2019, The Cochrane database of systematic reviews.

[20]  D. Bettenworth,et al.  Endoscopic Radiofrequency Ablation Prolongs Survival of Patients with Unresectable Hilar Cholangiocellular Carcinoma - A Case-Control Study , 2019, Scientific Reports.

[21]  Andrew Y. Wang,et al.  Endoscopic Retrograde Cholangiopancreatography-Guided Ablation for Cholangiocarcinoma. , 2019, Gastrointestinal endoscopy clinics of North America.

[22]  T. Rustagi,et al.  New Indications for Endoscopic Radiofrequency Ablation , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[23]  Xiaofeng Zhang,et al.  Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial , 2018, Endoscopy.

[24]  Wade M. Lee,et al.  Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures: a systematic review and meta-analysis. , 2017, Gastrointestinal endoscopy.

[25]  W. Fan,et al.  The safety and efficacy of percutaneous intraductal radiofrequency ablation in unresectable malignant biliary obstruction: A single-institution experience , 2017, BMC Cancer.

[26]  Guo-kun Ao,et al.  Percutaneous Intraductal Radiofrequency Ablation for Extrahepatic Distal Cholangiocarcinoma: A Method for Prolonging Stent Patency and Achieving Better Functional Status and Quality of Life , 2017, CardioVascular and Interventional Radiology.

[27]  Jun Wu,et al.  Endoscopic radiofrequency ablation may be preferable in the management of malignant biliary obstruction: A systematic review and meta‐analysis , 2016, Journal of digestive diseases.

[28]  W. Fan,et al.  Percutaneous intraductal radiofrequency ablation in the management of unresectable Bismuth types III and IV hilar cholangiocarcinoma , 2016, Oncotarget.

[29]  John E. Martin,et al.  Radiofrequency ablation for biliary malignancies , 2016, Current opinion in gastroenterology.

[30]  Xiaofeng Zhang,et al.  121 Endobiliary Radiofrequency Ablation Improve Overall Survival of Cholangiocarcinoma: A Multi-Center Randomized Control Study , 2016 .

[31]  C. Boustière,et al.  Safety and feasibility of endoscopic biliary radiofrequency ablation treatment of extrahepatic cholangiocarcinoma , 2016, Surgical Endoscopy.

[32]  N. Habib,et al.  Analysis of Endoscopic Radiofrequency Ablation of Biliary Malignant Strictures in Pancreatic Cancer Suggests Potential Survival Benefit , 2015, Digestive Diseases and Sciences.

[33]  N. Fukami,et al.  Impact of Radiofrequency Ablation on Malignant Biliary Strictures: Results of a Collaborative Registry , 2015, Digestive Diseases and Sciences.

[34]  M. Kahaleh,et al.  Comparison of Metal Stenting with Radiofrequency Ablation Versus Stenting Alone for Treating Malignant Biliary Strictures: Is There an Added Benefit? , 2014, Digestive Diseases and Sciences.

[35]  P. Jamidar,et al.  Intraductal Radiofrequency Ablation for Management of Malignant Biliary Obstruction , 2014, Digestive Diseases and Sciences.

[36]  M. Friedrich-Rust,et al.  Intraductal endoscopic radiofrequency ablation for the treatment of hilar non-resectable malignant bile duct obstruction. , 2014, World journal of gastrointestinal endoscopy.

[37]  M. Kuang,et al.  Thermal Ablation Versus Repeated Hepatic Resection for Recurrent Intrahepatic Cholangiocarcinoma , 2013, Annals of Surgical Oncology.

[38]  R. Dickinson,et al.  Percutaneous Intraductal Radiofrequency Ablation is a Safe Treatment for Malignant Biliary Obstruction: Feasibility and Early Results , 2013, CardioVascular and Interventional Radiology.

[39]  Burr J. Loew,et al.  Comparative performance of uncoated, self-expanding metal biliary stents of different designs in 2 diameters: final results of an international multicenter, randomized, controlled trial. , 2009, Gastrointestinal endoscopy.

[40]  M. Sydes,et al.  Practical methods for incorporating summary time-to-event data into meta-analysis , 2007, Trials.

[41]  D. Schuppan,et al.  Activation and dramatically increased cytolytic activity of tumor specific T lymphocytes after radio-frequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases. , 2006, World journal of gastroenterology.

[42]  Carl G. Figdor,et al.  In Situ Tumor Ablation Creates an Antigen Source for the Generation of Antitumor Immunity , 2004, Cancer Research.

[43]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[44]  G S Gazelle,et al.  Radiofrequency tissue ablation: physical principles and techniques for increasing coagulation necrosis. , 2001, Hepato-gastroenterology.